Should I buy Glaukos Corp. (GKOS) stock or is it too late?
⭐ The most reliable of them, either direction: Jefferies — 61% of its targets hit on this sector (137 calls tested). It aims for $210 (+27 %), call made on September 23, 2026, maturing on September 23, 2027 (21 d ago).
Firm-by-firm track record on Glaukos Corp.
| Firm | % right | Gain vs sector | Calls | Aims for |
|---|---|---|---|---|
| Stephens & Co. | 86 % | +89.0 % | 7 | $145 -12% |
| Piper Sandler | 75 % | +56.9 % | 8 | $195 +18% |
| Needham | 77 % | +45.2 % | 13 | $201 +21% |
| Truist Securities | 54 % | +29.2 % | 13 | $215 +30% |
| JP Morgan | 56 % | +23.7 % | 9 | $140 -15% |
| Stifel | 45 % | +20.4 % | 11 | $190 +15% |
| BTIG | 45 % | +19.5 % | 11 | $205 +24% |
| Citigroup | 56 % | -0.0 % | 9 | $188 +14% |
✅ Reasons to believe
- 91% of analysts rate it a buy (Buy consensus, 11 ratings) — a sign of market conviction.
- Median price target $195, i.e. +18% from the current price ($166).
⚠️ Reasons to hesitate
- Even the most reliable firm on GKOS, Stephens & Co. (86% hit rate, 7 scored calls), only targets $145 (call made on January 2, 2026, maturing on January 2, 2027) (-12%) in its most recent call. The stock may already have run past its target.
- The consensus is not unanimous: of 11 ratings, 1 is neutral.
- A 12-month target is not a guaranteed path: the price can fall in the meantime.
- No dividend: your return depends only on price appreciation.
The analyst consensus on GKOS
Median target $195 (+18%) · 11 ratings · Buy consensus
⚠️ Information, not investment advice. Past performance does not guarantee future results. Analyst targets on a ~12-month horizon.
Frequently asked questions
Should you invest in Glaukos Corp. now?
We won't decide for you. The facts: 91% of analysts rate it a buy, median target $195 (+18%), and Stephens & Co. (most reliable on GKOS, 86%) targets $145. Weigh that against valuation. This is not personalized advice.
Is it too late to invest in Glaukos Corp.?
Not according to analysts: the median target ($195) is still +18% above the current price ($166) (most reliable on GKOS: Stephens & Co., 86%). The real question isn't "too late" but the price-to-value gap and risk. Not advice.
Is Glaukos Corp. still worth investing in?
It depends on the gap between the price ($166) and its estimated value: analysts target $195 on median (+18%), with 91% buys (most reliable on GKOS: Stephens & Co., 86%). Cross-check with their real reliability on GKOS and the cautions above. Information, not advice.
What's the main risk in buying GKOS?
Even the most reliable firm on GKOS, Stephens & Co. (86% hit rate, 7 scored calls), only targets $145 (call made on January 2, 2026, maturing on January 2, 2027) (-12%) in its most recent call. The stock may already have run past its target.
→ Go deeper: the full Glaukos Corp. profile (consensus, analyst reliability, price target, performance).